Related Experiment Videos
Hepatic Encephalopathy.
1Department of Medicine, Lakeside VA Medical Center and Northwestern University, Chicago, Illinois 60611, USA.
The American Journal of Gastroenterology
|July 27, 2001
Summary
This study outlines management strategies for hepatic encephalopathy in cirrhosis patients, detailing treatments for acute, chronic, and minimal stages. Key interventions include nutritional support, lactulose, and antibiotics, with liver transplantation as a definitive option.
Area of Science:
- Hepatology
- Neurology
- Gastroenterology
Background:
- Hepatic encephalopathy (HE) is a complex neuropsychiatric complication of cirrhosis.
- It presents in acute, chronic, and minimal/subclinical forms, impacting patient quality of life.
Framework:
- Management involves addressing precipitating factors and implementing specific therapeutic measures.
- Treatment strategies are tailored to the severity and type of hepatic encephalopathy.
Implementation:
- Acute HE management includes nutritional support (IV glucose, enteral nutrition, controlled protein intake), lactulose administration (enema, NG tube, or oral), and avoidance of sedatives.
- Chronic HE management focuses on optimizing nutrition (dairy, vegetable-based diets, BCAAs), regular lactulose use, and antibiotics for refractory cases. Monitoring is crucial for chronic antibiotic use.
- Minimal HE may be treated with dietary changes and nonabsorbable disaccharides; benzodiazepines should be avoided.
Implications:
- Effective management of HE can improve neurological function and quality of life in cirrhosis patients.
- Liver transplantation is a consideration for refractory cases.
- Further research may explore advanced interventions for portal-systemic shunts and HE management.